Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, August 27, 2014

Valeant, Ackman get Oct. 6 trial over Allergan special meeting, (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

Valeant Pharmaceuticals International Inc and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $49 billion hostile takeover fight.Delaware Court of Chancery Chancellor Andre Bouchard ordered a three-day trial to begin on Oct. 6. Allergan had sought a trial on Nov. 24.Ackman's Pershing Square Capital Management hedge fund and Canada's Valeant sued Allergan on Friday, seeking a court order directing the maker of Botox anti-wrinkle treatment to call a special meeting by mid-November.Ackman and Valeant hope to use the meeting to oust a majority of Allergan's board, which has been trying to fend off the $49 billion takeover bid.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 0.4% or $-0.66/share to $163.31. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2748930 shares of AGN exchange hands on a given day and today's volume is recorded at 340699.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.28% or $-0.33/share to $116.77. In the past year, the shares have traded as low as $95.28 and as high as $153.10. On average, 3243810 shares of VRX exchange hands on a given day and today's volume is recorded at 552896.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.73% or $-0.93/share to $127.29. In the past year, the shares have traded as low as $99.90 and as high as $170.45. On average, 352237 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 49216.



Source